Discover the Programme

The scientific programme for the IDF World Diabetes Congress 2025 will feature 10 streams focused on:

  • Basic and Translational Science (BTS)
  • Classification and Differential Management of Diabetes (CDM)
  • Technology and Artificial Intelligence (TAI)
  • Diabetes Complications (DC)
  • Type 1 Diabetes (T1D)
  • Public Health and Policy (PHP)
  • Education and Integrated Care (EIC)
  • Epidemiology and Prevention of Diabetes (EPD)
  • Women and Diabetes (WAD)
  • Living with Diabetes (LWD)

Browse the full scientific programme  and e-poster gallery online.

Scientific programme
E-poster gallery

Full programme at-a-glance

The time zone for the IDF World Diabetes Congress 2025 is ICT (UTC+7).

The scientific programme starts on Tuesday, 8 April. The opening ceremony will be held on Monday, 7 April at 17:00 (ICT).

IDF 2025 programme at a glance

Fireside Chats

An informal chat in an intimate semi-circle where speakers and participants  discuss  various topics in a comfortable and relaxed surrounding. This layout allows for a more intimate back and forth interaction with the presenter. The presenter and audience can engage in a more casual one-to-one conversation.

Open-Space-Event

The open-space-event is an action-orientated way of engaging small groups of participants in discussions about key areas. Small 4-6 stations will be formed with flip-charts at each side. These stations are handled by facilitators who carry out the discussion with the participants. Two roving Agent Provocateurs will be initiating discussions at each station. 

The small groups can brainstorm ideas and these will be collectively shared on a white wall at the end of the session where attendees can leave sticky notes.

Bubble Debates

Bubble debates are a powerful format where two opposing teams give their view on a given topic and the audience will be encouraged to vote for the most convincing argument.

The bubble debate will start with two lead speakers who will set the scene. The discussion will be on “What is value to patients and the responses of policy makers and healthcare systems”. After their thought provoking talk, speakers of two opposing teams will debate for 5 min for or against the subject. The audience will then vote for the top three debaters who then will talk for another 5 mins. The audience votes for the final winner who takes it all!

Speed Dating

This format will allow participants to exchange ideas with members of different associations. Small tables will be set-up where association members are ready to engage in a small conversation with the participants.  Participants are given a short time to speak to each member.  After a stop signal, participants form a new pair with a new person at another table and so forth.

The Speed Dating session will be followed by an engaging discussion with policy makers on the topic of “can member associations influence decision making?” and finishes with an overall discussion between all participants.

Message from Programme Chair

On behalf of the Programme Committee, I am proud to invite you to the IDF Congress 2022 in Lisbon.

It is a perfect place for all colleagues from around the world to meet and greet, update scientific knowledge, share new data and innovations and exchange experiences.

The scientific programme of the IDF Congress 2022 will cover a wide range of topics relevant to diabetes. Across eight parallel streams, it will address the basic science and biology of diabetes, the development and application of new drugs, therapies and technologies, the latest information from clinical trials, the burden of diabetes and its complications in populations around the globe, the prevention of diabetes, and policy and advocacy issues critical to tackling the diabetes pandemic.

A particular focus on issues relating to women and the voice of people with diabetes will be a feature of the programme. Speakers will include world-leading experts, early career researchers, and people at the coalface who work with or live with diabetes. A range of different formats from lectures, to debates and workshops will present cutting-edge findings and state-of-the-art reviews. The highly interactive environment will encourage exchanges of views and the development of new ideas and collaborations.

We look forward to welcoming you all to Lisbon for an inspiring and memorable IDF Congress 2022.

Prof. Jonathan Shaw
Chair, Programme Committee

Programme highlights

Dr. Ranjit Mohan Anjana

Applications of big data in diabetes epidemiology

Tuesday, 6 December

Dr. Ranjit Mohan Anjana will discuss using 'big' survey data to get at the heart of the diabetes epidemic in low- and middle-income countries

Dr. Timotheus Dorh

Diabetes prevention and remission

Tuesday, 6 December

Dr. Timotheus Dorh will discuss whether diabetes prevention strategies are working.

Jazz Sethi

The biggest obstacle to change is breaking through the barriers

Wednesday, 7 December

Jazz Sethi will discuss how social perceptions and judgements associated with type 1 diabetes are creating barriers to change.

Dr Winnie Chee Siew Swee

A transcultural approach to diabetes-specific nutrition

Wednesday, 7 December

Dr Winnie Chee Siew Swee will look at the importance of understanding cultural influences on dietary self-management and tailoring interventions to individual needs.

Prof. Christian Herder

Heterogeneity of diabetes

Wednesday, 7 December

Prof. Christian Herder will discuss the implications for clinical practice of recent studies indicating that prediabetes and diabetes can be reclassified into novel subgroups.

Dr. Ravi Retnakaran

Is GDM a risk factor for CVD?

Thursday, 8 December

Dr. Ravi Retnakaran will make the argument that the diagnosis of gestational diabetes potentially provides a unique opportunity for the primary prevention of cardiovascular disease in women.”

Prof Brian Oldenburg

Prevention of type 2 diabetes

Thursday, 8 December

Prof Brian Oldenburg will look at the impact of diabetes prevention trials and highlight the urgent need to develop intervention approaches tailored to local contexts.

Dr. Helena Canhão

Novel tactics to address diabetes

Tuesday, 6 December

Dr. Helena Canhão will discuss the relationship between skeletal muscle disorders and diabetes.

Prof. Margaret McGill

Diabetes education and care through one century

Tuesday, 6 December

Prof. Margaret McGill will look at current and future perspectives for diabetes education in high-income countries.

Daniela Rojas

Coping with change

Wednesday, 7 December

Daniela Rojas Jiménez will discuss how life transitions can often impact the mental and emotional health of people living with diabetes and their caregivers.

Paula Chinchilla

Models of integrated care relevant to people living with diabetes

Wednesday, 7 December

Paula Chinchilla will be a panellist for a discussion on going beyond insulin pricing.

Dr Mary Loeken

Diabetes: preventing malformations

Wednesday, 7 December

Dr Mary Loeken will present evidence for the cellular mechanisms by which maternal diabetes causes congenital malformations.

Prof Norbert Stefan

Envisioning the future of diabetes management

Thursday, 8 December

Prof Norbert Stefan will discuss non-alcoholic fatty liver disease (NAFLD) as a cause and complication of diabetes.

Prof Anoop Misra

Diabetes and infection

Thursday, 8 December

Prof Anoop Misra will discuss the co-epidemic of tuberculosis and diabetes in India

Julia Mader

Diabetes technology: Glycemic metrics and outcomes

Tuesday, 6 December

Julia Mader will discuss how CGM is a potent tool to improve and assess glycemic control in primary care networks

Dr. Petter Bjornstad

Updates on diabetic kidney disease

Tuesday, 6 December

Dr. Petter Bjornstad will present metabolic bariatric surgery as a promising model to uncover novel therapeutic targets to mitigate diabetic kidney disease.

Dr. Sylvia Kehlenbrink

Diabetes in humanitarian crisis situations

Wednesday, 7 December

Dr. Sylvia Kehlenbrink will discuss the importance of alliances and the past, present and future of the Boston declaration.

Dr Clifford J. Bailey

Oral antidiabetic medications

Thursday, 8 December

Dr Clifford J. Bailey will discuss the role of SGLT2 inhibitors across the cardio-metabolic-renal risk spectrum

Prof. Jonathan Valabhji

Diabetes prevention and remission

Thursday, 8 December

Prof. Jonathan Valabhji will present experiences and evaluation findings around the implementation at scale of type 2 diabetes prevention and remission programmes in the UK.

Prof. Tatjana Milenkovic

Diabetes education and care through one century

Thursday, 8 December

Prof. Tatjana Milenkovic will discuss the effectiveness and long-term benefits of DSME programmes for the treatment of type 2 diabetes

Dr Vladimir Carvalho

Long-term exercise preserves pancreatic islet structure and beta-cell mass through attenuation of islet fibrosis

Thursday, 8 December

Dr. Vladimir Carvalho will discuss the effect of regular exercise training on islet fibrosis and β-cell mass

Dr. Phyllisa Deroze

Beyond Insulin Pricing

Tuesday, 6 December

Dr. Phyllisa Deroze will share her story of being misdiagnosed, mistreated and receiving incorrect information related to her diabetes.

Dr Richard Bergman

Novel insights in insulin clearance

Tuesday, 6 December

Dr Richard Bergman will discuss the effect of liver degradation of insulin on the prediction of type 2 diabetes and the possible importance of this new understanding on the development of the condition.

Manny Hernandez

Peer support in diabetes care

Wednesday, 7 December

Manny Hernandez will discuss the importance of peer support for the diabetes community

Dr Paramesh Shamanna

Debates on hot topics

Wednesday, 7 December

Dr Paramesh Shamanna will discuss whether lifestyle or surgery is the best option for the remission of type 2 diabetes.

Dr Tongzhi Wu

Managing type 2 diabetes by exercise and nutritional approaches

Thursday, 8 December

Dr Tongzhi Wu will discuss the implications of taste in the management of type 2 diabetes

Dr. Jill Norris

Beyond type 1 diabetes

Thursday, 8 December

Dr. Jill Norris will discuss whether the epidemiology of type 1 diabetes is changing and why.